Gastroenterology

Back to articles

Cisapride Marketing Ends, but Drug Will Be Available Through Physicians

KEY POINT

The plethora of life-threatening drug interactions with cisapride (Propulsid—Janssen Pharmaceutica) has ended the drug’s marketing in the United States. However, the company will continue to make the promotility agent available through physicians to patients who are unable to obtain relief from alternative agents.